Cell Biotech Co., Ltd. (KOSDAQ:049960)
 11,790
 +70 (0.60%)
  At close: Oct 28, 2025
Cell Biotech Revenue
Cell Biotech had revenue of 11.91B KRW in the quarter ending June 30, 2025, a decrease of -5.16%. This brings the company's revenue in the last twelve months to 47.46B, down -12.28% year-over-year. In the year 2024, Cell Biotech had annual revenue of 49.91B, down -7.20%.
Revenue (ttm) 
 47.46B
Revenue Growth 
 -12.28%
P/S Ratio 
 1.70
Revenue / Employee 
 469.86M
Employees 
 101
Market Cap 
80.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 49.91B | -3.87B | -7.20% | 
| Dec 31, 2023 | 53.79B | 3.26B | 6.46% | 
| Dec 31, 2022 | 50.53B | 3.65B | 7.79% | 
| Dec 31, 2021 | 46.87B | 1.29B | 2.83% | 
| Dec 31, 2020 | 45.58B | -377.42M | -0.82% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Samsung Electronics | 315.59T | 
| Hyundai Motor Company | 182.25T | 
| Kia Corporation | 111.04T | 
| SK hynix | 84.09T | 
| LG Energy Solution | 25.16T | 
| Hanwha Aerospace | 19.25T | 
| Doosan Enerbility | 16.30T | 
| HD Hyundai Heavy Industries | 15.58T |